These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9649134)
21. [Prognostic significance of microvessel density in ovarian cancer]. Rossochacka-Rostalska B; Gisterek IJ; Suder E; Szelachowska JK; Matkowski RA; Lacko A; Kornafel JA Wiad Lek; 2007; 60(3-4):129-37. PubMed ID: 17726864 [TBL] [Abstract][Full Text] [Related]
22. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma. Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402 [TBL] [Abstract][Full Text] [Related]
23. Expression and correlation of Lewis y antigen and integrins α5 and β1 in ovarian serous and mucinous carcinoma. Li Q; Liu S; Lin B; Yan L; Wang Y; Wang C; Zhang S Int J Gynecol Cancer; 2010 Dec; 20(9):1482-9. PubMed ID: 21119363 [TBL] [Abstract][Full Text] [Related]
24. CD31 and CD34 expression as immunohistochemical markers of endothelial transdifferentiation in human cutaneous melanoma. Pisacane AM; Picciotto F; Risio M Cell Oncol; 2007; 29(1):59-66. PubMed ID: 17429142 [TBL] [Abstract][Full Text] [Related]
25. Differential expression of IL-8 and IL-8 receptors in benign, borderline and malignant ovarian epithelial tumours. Browne A; Sriraksa R; Guney T; Rama N; Van Noorden S; Curry E; Gabra H; Stronach E; El-Bahrawy M Cytokine; 2013 Oct; 64(1):413-21. PubMed ID: 23727325 [TBL] [Abstract][Full Text] [Related]
26. Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. Kuzu I; Bicknell R; Harris AL; Jones M; Gatter KC; Mason DY J Clin Pathol; 1992 Feb; 45(2):143-8. PubMed ID: 1371777 [TBL] [Abstract][Full Text] [Related]
27. The influence of microvessel density on ovarian carcinogenesis. Stone PJ; Goodheart MJ; Rose SL; Smith BJ; DeYoung BR; Buller RE Gynecol Oncol; 2003 Sep; 90(3):566-71. PubMed ID: 13678725 [TBL] [Abstract][Full Text] [Related]
28. Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31. de la Taille A; Katz AE; Bagiella E; Buttyan R; Sharir S; Olsson CA; Burchardt T; Ennis RD; Rubin MA Am J Clin Pathol; 2000 Apr; 113(4):555-62. PubMed ID: 10761458 [TBL] [Abstract][Full Text] [Related]
29. Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas. Poblet E; Gonzalez-Palacios F; Jimenez FJ Virchows Arch; 1996 Jul; 428(4-5):217-21. PubMed ID: 8764929 [TBL] [Abstract][Full Text] [Related]
30. Quantification of angiogenesis in cervical cancer: a comparison among three endothelial cell markers. Vieira SC; Zeferino LC; Da Silva BB; Aparecida Pinto G; Vassallo J; Carasan GA; De Moraes NG Gynecol Oncol; 2004 Apr; 93(1):121-4. PubMed ID: 15047224 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical analysis of vascular density and area in colorectal carcinoma using different markers and comparison with clinicopathologic prognostic factors. Moreira LR; Schenka AA; Latuf-Filho P; Penná AL; Lima CS; Soares FA; Trevisan MA; Vassallo J Tumour Biol; 2011 Jun; 32(3):527-34. PubMed ID: 21222066 [TBL] [Abstract][Full Text] [Related]
32. Proliferation and maturation of intratumoral blood vessels in women with malignant ovarian tumors assessed with cancer stem cells marker nestin and platelet derived growth factor PDGF-B. Czekierdowska S; Stachowicz N; Chróściel M; Czekierdowski A Ginekol Pol; 2017; 88(3):120-128. PubMed ID: 28397199 [TBL] [Abstract][Full Text] [Related]
33. Microvessel density assessment in benign and malignant endometrial changes. Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753 [TBL] [Abstract][Full Text] [Related]
34. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions. Ding S; Li C; Lin S; Yang Y; Liu D; Han Y; Zhang Y; Li L; Zhou L; Kumar S Hum Pathol; 2006 Jul; 37(7):861-6. PubMed ID: 16784986 [TBL] [Abstract][Full Text] [Related]
35. Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours. Tan Y; Sinniah R; Bay BH; Singh G J Pathol; 1999 Sep; 189(1):60-5. PubMed ID: 10451489 [TBL] [Abstract][Full Text] [Related]
36. Pattern of HER-2 Gene Amplification and Protein Expression in Benign, Borderline, and Malignant Ovarian Serous and Mucinous Neoplasms. Mohammed RAA; Makboul R; Elsers DAH; Elsaba TMAM; Thalab AMAB; Shaaban OM Int J Gynecol Pathol; 2017 Jan; 36(1):50-57. PubMed ID: 27309616 [TBL] [Abstract][Full Text] [Related]
37. Expression of a novel endothelial marker, C-type lectin 14A, in epithelial ovarian cancer and its prognostic significance. Krishna Priya S; Kumar K; Hiran KR; Bindhu MR; Nagare RP; Vijaykumar DK; Ganesan TS Int J Clin Oncol; 2017 Feb; 22(1):107-117. PubMed ID: 27567920 [TBL] [Abstract][Full Text] [Related]
38. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma. Sakurai T; Okumura H; Matsumoto M; Uchikado Y; Owaki T; Kita Y; Setoyama T; Omoto I; Kijima Y; Ishigami S; Natsugoe S Anticancer Res; 2014 Jul; 34(7):3431-8. PubMed ID: 24982351 [TBL] [Abstract][Full Text] [Related]
39. Ephrin B expression in epithelial ovarian neoplasms correlates with tumor differentiation and angiogenesis. Castellvi J; Garcia A; de la Torre J; Hernandez J; Gil A; Xercavins J; Ramón y Cajal S Hum Pathol; 2006 Jul; 37(7):883-9. PubMed ID: 16784989 [TBL] [Abstract][Full Text] [Related]
40. [Lymphatic metastasis and VEGF-C expression in ovarian epithelial tumors]. Ding MX; Li JC; Tang XH Shi Yan Sheng Wu Xue Bao; 2003 Dec; 36(6):445-52. PubMed ID: 14724935 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]